로딩 중…
지수 로딩 중…
Absci Corporation
ABSI· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$7.93+1.93%
2026-08-03
Financials
Valuation Metrics
Absci Corporation's Market Cap is $1.24B. At end of 2025 it was $502M. Ranked #2373 of 3,112 in US market (top 76%), #954 of 1,445 on NASDAQ (top 66%), #175 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 65%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $1.24B | US#2,373/3,112 Sec#175/269 |
| Revenue | $2M | US#2,957/3,112 Sec#197/269 |
| Net Income | $-118M | US—/3,112 Sec—/269 |
| Total Assets | $196M | US#2,982/3,112 Sec#250/269 |
| Net Assets | $172M | US#2,780/3,112 Sec#208/269 |
| Value | ||
| P/B | 7.19x | US#2,432/3,112 Sec#177/269 |
| P/S | 673.38x | US#2,944/3,112 Sec#196/269 |
| FCF Yield | -7.97% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROE | -68.87% | US#2,797/3,112 Sec#198/269 |
| ROA | -60.55% | US#3,002/3,112 Sec#237/269 |
| Op. Margin | -7000.82% | US#2,956/3,112 Sec#195/269 |
| Revenue Growth | -81.76% | US#2,920/3,112 Sec#175/269 |
| Financial Health | ||
| Debt Ratio | 13.74% | US#156/3,112 Sec#66/269 |
| Total Debt | $4M | US#2,861/3,112 Sec#219/269 |
| FCF | $-99M | US#2,586/3,112 Sec#152/269 |
| Cash | $9M | US#2,962/3,112 Sec#267/269 |
| Current Ratio | 6.59x | US#365/3,112 Sec#118/269 |
| Performance | ||
| 1Y Return | 173.45% | US#139/3,112 Sec#46/269 |
| 1M Return | -31.76% | US#3,074/3,112 Sec#258/269 |
| From 52W High | -34.25% | US#2,339/3,112 Sec#177/269 |
| 1Y MDD | -54.00% | US#2,540/3,112 Sec#196/269 |
| Trading | ||
| Volume | 2,148,040 shares | US#841/3,112 Sec#74/269 |
| Trading Value | $17M | US#2,073/3,112 Sec#160/269 |
| Per Share | ||
| EPS | $-0.60 | US—/3,112 Sec—/269 |
| BPS | $1.46 | US#2,569/3,112 Sec#187/269 |